BridgeMD
New treatment option for Adhesive Capsulitis of the Shoulder
Official title Transcutaneous Auricular Vagus Nerve Stimulation Added to Physiotherapy for Adhesive Capsulitis
ClinicalTrials.gov ID: NCT07711353
What this study is testing
- What it's testing
- This randomized, sham-controlled study will evaluate whether transcutaneous auricular vagus nerve stimulation (taVNS), when added to standard physiotherapy, improves pain, shoulder function, range of motion, and quality of life in adults with adhesive capsulitis. A total of 40 participants aged 18 to 65 years will be randomly assigned to one of two groups.
- Time commitment: about 3 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age between 18 and 65 years.
- Clinical diagnosis of adhesive capsulitis confirmed by physical examination and, when clinically indicated, imaging.
- Shoulder pain and limitation of shoulder range of motion for at least 3 months.
- Provision of written informed consent.
- General health status sufficient to participate in standard physiotherapy and active or sham transcutaneous auricular vagus nerve stimulation.
You likely can't join if
- Shoulder stiffness secondary to trauma, surgery, infection, or tumor.
- Rotator cuff tear, advanced glenohumeral osteoarthritis, or inflammatory rheumatic disease.
- Glucocorticoid injection into the affected shoulder within the previous 3 months.
- Surgical intervention involving the affected shoulder within the previous 6 months.
- Active infection or skin lesion in the shoulder region.
- Cervical radiculopathy, brachial plexopathy, stroke, or another neurological disorder affecting the upper extremity.
See the full eligibility criteria
- Age between 18 and 65 years.
- Clinical diagnosis of adhesive capsulitis confirmed by physical examination and, when clinically indicated, imaging.
- Shoulder pain and limitation of shoulder range of motion for at least 3 months.
- Provision of written informed consent.
- General health status sufficient to participate in standard physiotherapy and active or sham transcutaneous auricular vagus nerve stimulation.
- Ability to comply with the planned treatment sessions and outcome assessments.
- Shoulder stiffness secondary to trauma, surgery, infection, or tumor.
- Rotator cuff tear, advanced glenohumeral osteoarthritis, or inflammatory rheumatic disease.
- Glucocorticoid injection into the affected shoulder within the previous 3 months.
- Surgical intervention involving the affected shoulder within the previous 6 months.
- Active infection or skin lesion in the shoulder region.
- Cervical radiculopathy, brachial plexopathy, stroke, or another neurological disorder affecting the upper extremity.
- Presence of a cardiac pacemaker or another implanted electronic device.
- Pregnancy or breastfeeding.
- Serious systemic disease or cognitive impairment that may prevent compliance with the study protocol.
- Known intolerance or previous adverse reaction to transcutaneous electrical stimulation.
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 3 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.